Applied Optoelectronics stock jumps 14% to start 2026 as AI data-center optics rally

Applied Optoelectronics stock jumps 14% to start 2026 as AI data-center optics rally

NEW YORK, January 4, 2026, 07:17 ET — Market closed

  • Applied Optoelectronics surged in the first U.S. session of 2026, outpacing other optical-networking names.
  • The move tracked renewed appetite for “AI infrastructure” stocks tied to data-center spending.
  • Investors now focus on follow-through into Monday and the company’s next quarterly update.

Applied Optoelectronics’ shares jumped 13.6% in the last regular session on Friday, closing at $39.60. The stock traded between $35.82 and $40.06 during the session.

The outsized move mattered because it came on the first trading day of 2026, when positioning and thinner liquidity can amplify swings in smaller, higher-volatility names.

“Value is outperforming growth and AI infrastructure is up,” said Jed Ellerbroek, portfolio manager at Argent Capital, describing Friday’s broader tape. 1

Applied Optoelectronics’ gain also landed alongside strength in optical and networking peers. Lumentum rose 4.7%, Coherent climbed 5.3%, and Ciena added 5.2% in the last session.

Applied Optoelectronics makes lasers and high-speed optical transceivers — devices that convert electrical signals into light so data can move through fiber. Demand for faster links has been tied to AI-driven data center buildouts, where networks must handle heavier traffic.

In its most recent product update, the company said on Dec. 10 it received its first volume order for 800G data-center transceivers from a “major hyperscale customer,” and reiterated an expectation that 800G shipments could contribute $4 million to $8 million of fourth-quarter revenue. The company also said the customer had placed orders totaling nearly $22 million for 400G transceivers, including $13 million delivered so far in the fourth quarter. 2

On Dec. 18, Applied Optoelectronics said it introduced a 400-milliwatt narrow-linewidth pump laser aimed at silicon photonics and co-packaged optics — approaches designed to push optical connections closer to chips to reduce power and improve speed in AI systems. The company said samples were available to select customers, with volume production expected later in 2026. 3

Investors have also been watching the company’s capital-raising flexibility. A Nov. 7 filing showed Applied Optoelectronics entered an equity distribution agreement that allows it to sell up to $180 million of stock through an “at-the-market” program — a structure that lets companies drip shares into the market over time at prevailing prices rather than via a single deal. 4

The company’s latest quarterly update, issued with third-quarter results on Nov. 6, included fourth-quarter targets for revenue of $125 million to $140 million and non-GAAP gross margin of 29% to 31%. 5

Friday’s broader market backdrop was subdued. U.S. stocks ended mixed in a holiday-shortened week, with the Dow and S&P 500 up and the Nasdaq fractionally lower as Treasury yields rose. 1

Before the next session, traders will be watching whether Applied Optoelectronics can hold the $40 area it briefly tested on Friday, and whether the bid in optical-networking peers persists as U.S. markets reopen on Monday.

The next clear company catalyst is the fourth-quarter report. Zacks lists Applied Optoelectronics’ earnings date as an estimate around Feb. 25, 2026, and shows Wall Street expectations for another quarterly loss. 6

Stock Market Today

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
ACM Research stock jumps nearly 14% to start 2026 as chip rally returns — what to watch next
Previous Story

ACM Research stock jumps nearly 14% to start 2026 as chip rally returns — what to watch next

Aberdeen City Council meeting Jan. 5: property-tax appeals board, $205k excavator and bridge payment on agenda
Next Story

Aberdeen City Council meeting Jan. 5: property-tax appeals board, $205k excavator and bridge payment on agenda

Go toTop